| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/20/2008 | CN100411628C Combination of sterically hindered platinum coordination compound and no-platinum anticarcinogen, and use thereof |
| 08/20/2008 | CN100411620C Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/20/2008 | CN100411618C Use of compounds that are effective as selective opiate receptor modulators |
| 08/19/2008 | US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping |
| 08/19/2008 | US7414120 enhances ubiquitination of phosphorylated I kappa B; human E3 ubiquitin ligase polypeptides; inflammatory diseases, autoimmune diseases, cancer and viral infections |
| 08/19/2008 | US7414108 novel prostatic acid phosphatase and corresponding coding region derived from mouse; immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation. |
| 08/19/2008 | US7414107 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 08/19/2008 | US7414073 Baccatin III analog conjugated to cell binding agent such as monoclonal antibody through a link from the oxygen atom at the C-7 position; treating cancer, rheumatoid arthritis, transplant rejection, viral and parasite infections |
| 08/19/2008 | US7414068 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 08/19/2008 | US7414065 Methods to modulate conditions mediated by the CXCR4 receptor |
| 08/19/2008 | US7414063 e.g. 2-(2-bromo-4-fluoro-phenoxy)-ethyl]-[2-(isoquinoline-5-sulfonylamino)-ethyl]-carbamic acid tert-butyl ester; serine/threonine kinase inhibitor; anticarcinogenic agent; solid tumor, leukemia |
| 08/19/2008 | US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/19/2008 | US7414053 cyclin-dependent and serine/threonine kinases inhibitor; cell cycle arrest in the G2/M phase; antiproliferative and antitumor agent: leukemia, sarcoma, lung, breast, prostate, pancreas cancer; autoimmune diseases: arthritis, Alzheimer's disease |
| 08/19/2008 | US7414048 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 08/19/2008 | US7414042 Topically applying betulinic acid or a betulinic acid derivative to tumor site |
| 08/19/2008 | US7414026 Inhibitors of NF-kappaB activation |
| 08/19/2008 | US7414024 B-cell differentiation factor (il-6); anticancer agents; antisense agents; monoclonal antibody |
| 08/19/2008 | US7414023 polypeptides/peptidomimetics; solid phase synthesis; for use in diagnositc assays |
| 08/19/2008 | US7414022 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 08/19/2008 | US7414020 DNA expression vector; host cell transformed, transfected or infected with the vector; transgenic cell, tissue or organism; HCDS1 protein |
| 08/19/2008 | US7413895 Nucleotide sequences coding cell surface protein associated with amino acid transport for use in identifying modlator for treatment and prevention of cell proliferative disorders; antitumor agents; antiproliferative agents |
| 08/19/2008 | US7413754 Administering a photoestrogen for treating urinary bladder infection and dry vagina; plant extracts is obtained from solvent extraction |
| 08/19/2008 | US7413736 Administering anti-idiotype antibody or antibody fragment comprising heavy chain variable region sequences and light chain variable region sequences conjugated to a soluble immunogenic carrier protein |
| 08/19/2008 | CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/19/2008 | CA2370003C A composition and method for the enhancement of the efficacy of drugs |
| 08/19/2008 | CA2369448C Medicament for inhibiting nf-kb |
| 08/19/2008 | CA2318372C A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use |
| 08/19/2008 | CA2257448C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 08/19/2008 | CA2200871C Aniline derivatives |
| 08/19/2008 | CA2151801C 3'-modified oligonucleotide derivatives |
| 08/14/2008 | WO2008098208A2 Gnaq mutations in melanoma |
| 08/14/2008 | WO2008098178A2 Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| 08/14/2008 | WO2008098138A1 Synthetic macrocyclic compounds for treating cancer |
| 08/14/2008 | WO2008098115A2 Optimized igf-1r antibodies and methods of using the same |
| 08/14/2008 | WO2008098058A1 Pi 3-kinase inhibitors and methods of their use |
| 08/14/2008 | WO2008097467A1 Anti-methylation-controlled j protein antibodies and uses thereof |
| 08/14/2008 | WO2008096865A1 Therapeutic agent for disease induced by dysfunction or degeneration of organ |
| 08/14/2008 | WO2008096831A1 Therapeutic agent for cancer |
| 08/14/2008 | WO2008096829A1 Tricyclic compounds |
| 08/14/2008 | WO2008096779A1 C70-containing liposome, method for producing the same, and use of the same |
| 08/14/2008 | WO2008096769A1 Pharmaceutical compositions containing substituted cercosporamide derivatives |
| 08/14/2008 | WO2008096755A1 Vanilloid receptor (vr1) inhibitor and use thereof |
| 08/14/2008 | WO2008096690A1 Polyethylene glycol derivative |
| 08/14/2008 | WO2008096547A1 Anti-tumor composition comprising tissue-accumulating chitosan gel |
| 08/14/2008 | WO2008096268A2 Autologous lymph node transfer in combination with vegf-c or vegf-d growth factor therapy to treat secondary lymphedema and to improve reconstructive surgery |
| 08/14/2008 | WO2008096218A1 2-amin0-5, 7-dihydr0-6h- pyrrolo [3, 4-d] pyrimidine derivatives as hsp-90 inhibitors for treating cancer |
| 08/14/2008 | WO2008096155A1 Composition comprising a glycolytic inhibitor and a ring system comprising a sulphamate group for the treatment of cancer |
| 08/14/2008 | WO2008096129A1 Nitrogen containing hetrocyclic compounds useful as bifunctional modulators of m3 receptors and beta- 2 receptors |
| 08/14/2008 | WO2008096028A1 Glycosylate derivatives of mithramycin, method of preparation and uses thereof |
| 08/14/2008 | WO2008095847A1 Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof |
| 08/14/2008 | WO2008095366A1 Porphyrin derivatives, preparation methods and the uses as small molecular antioxidant thereof |
| 08/14/2008 | WO2008095312A1 Use of high dose concentrations of gaseous nitric oxide |
| 08/14/2008 | WO2008095311A1 Use of gaseous nitric oxide as an anti-cancer agent |
| 08/14/2008 | WO2008095276A1 Novel non-toxic composition and method of using such for treating a degenerative or an immune system-related disease |
| 08/14/2008 | WO2008079972A3 4-{4- [ ({3-tert-butyl-1- [3- (hydroxymethyl) phenyl] - 1h- pyrazol- 5 -yl } carbamoyl) -amin o] -3-chlorophenoxy} -n-methylpyridine-2-carboxamide as an inhibitor of the vegfr kinase for the treatment of cancer |
| 08/14/2008 | WO2008077885A3 2- [(phenylamino) -pyrimidin-4ylamin0] -cyclopentane carboxamide derivatives and related compounds as inhibitors of kinases of the cell cycle for the treatment of cancer |
| 08/14/2008 | WO2008077077A3 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors |
| 08/14/2008 | WO2008070100A8 Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof |
| 08/14/2008 | WO2008065543A2 Modified soluble fgf receptor fc fusions with improved biological activity |
| 08/14/2008 | WO2008064093A3 Salts and crystal forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile |
| 08/14/2008 | WO2008049855A3 7-azaindole derivatives as c-met kinase inhibitors |
| 08/14/2008 | WO2008033557A3 Click chemistry-derived cyclic peptidomimetics as integrin markers |
| 08/14/2008 | WO2008026223B1 An aqueous formulation for selective targeting and delivering gene to cancer cells |
| 08/14/2008 | WO2008015383A3 Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies |
| 08/14/2008 | WO2008007262A3 Bisnaphthalimidopropyl derivative compounds with anti-parasite and anti-cancer activity |
| 08/14/2008 | WO2007081835A3 Modulators of hypoxia inducible factor-1 and related uses |
| 08/14/2008 | WO2007072158A8 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 08/14/2008 | WO2007072153A8 Carbonylamino pyrrolopyrazoles, potent kinase inhibitors |
| 08/14/2008 | WO2007066189A3 Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea |
| 08/14/2008 | US20080195033 Method of Delivery of Therapeutic Metal Ions, Alloys and Salts |
| 08/14/2008 | US20080194697 ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane, used for treating prostate cancer, prostatitis and benign prostatic hyperplasia |
| 08/14/2008 | US20080194692 Polymorphs of suberoylanilide hydroxamic acid |
| 08/14/2008 | US20080194691 Apoptosis Promoters |
| 08/14/2008 | US20080194690 Pharmaceutical Formulations Of Hdac Inhibitors |
| 08/14/2008 | US20080194683 Medicament for preventing and/or treating peripheral neuropathies |
| 08/14/2008 | US20080194681 Novel Inhibitors of Histone Deacetylase for the Treatment of Disease |
| 08/14/2008 | US20080194680 Platinum analogs with bis-nitrile-containing ligands |
| 08/14/2008 | US20080194675 Mixture of Catechins or Rather Polyphenols Extracted from Chinese Green Tea or Other Vegetables for the Prevention of Prostate Cancer and for the Treatment of Prostate Hypertrophy (Bph) |
| 08/14/2008 | US20080194672 Growth hormone secretagogue (ghrelin) receptor; gastrointestinal disorders; gastroesophageal reflux disease (GERD), gastric ulcers, Crohn's disease |
| 08/14/2008 | US20080194669 T Type Calcium Channel Blockers and the Treatment of Diseases |
| 08/14/2008 | US20080194666 Gonadotropin-releasing hormone antagonist (GnRH antagonist); insecticides, nematocides and molluscicides; sexual disorders |
| 08/14/2008 | US20080194663 Novel sustained release polymer |
| 08/14/2008 | US20080194659 Cinnamic, Phenylpropiolic and Phenylpropanoic Acid Derivatives Useful as Anti-Tumor Agents |
| 08/14/2008 | US20080194653 Using a thiadiazole drug; anticancer agents |
| 08/14/2008 | US20080194651 Nitroderivatives as drugs for diseases having an inflammatory basis |
| 08/14/2008 | US20080194643 Using pyrrolidonedicarboxamide compound; therapy for thrombosis, cardiovascular disorders; myocardoim infraction; restenosis; atherosclerosis; anticancer agents; sepsis; antidiabetic agents |
| 08/14/2008 | US20080194622 Antidepressants; anxiolytic agents;schizophrenia; cognition activators |
| 08/14/2008 | US20080194614 Using mixture of hydroxy-3-methylglutaryl coenzyme a inhibitor and rapamycin; anticholesterol agents; dyslipidemia; atherosclerosis; antiarthritic agents; inflammatory bowel disorders; restenosis; transplant rejection |
| 08/14/2008 | US20080194606 Pyrazolyl-Amino-Substituted Pyrimidines and Their Use in the Treatment of Cancer |
| 08/14/2008 | US20080194605 Antitumor agents; kinase inhibitors; angiogenesis inhibitors; arteriosclerosis ; antiinflammatory agents |
| 08/14/2008 | US20080194596 Therapeutic Combination Including a Selective Erbb2 Inhibitor |
| 08/14/2008 | US20080194593 Asthma therapy; antidiarrhea agents; antiinflammatory agents; gastrointestinal disorders; anticancer agents; cardiovascular disorders |
| 08/14/2008 | US20080194584 Nitrogen Heteroaromatic Compounds Which Bind To The Active Site Of Protein Kinase Enzymes |
| 08/14/2008 | US20080194583 Tubulin Inhibitors |
| 08/14/2008 | US20080194582 3,5-Diphenyl-4,5-dihydro-1H-dipyrazole derivatives such as {2-[1-acetyl-3-(2,5-difluorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-5-yl]ethyl}(dimethyl)silanol that are useful for treating cancer |
| 08/14/2008 | US20080194580 Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl Ureas |
| 08/14/2008 | US20080194579 Antiinflammatory agents; chronic obstructive pulmonary disease; antihistamines; transplant rejection; antitumor agents |
| 08/14/2008 | US20080194578 Quinazoline based egfr inhibitors containing a zinc binding moiety |
| 08/14/2008 | US20080194572 5,6,7,8-tetrahydropteridine derivatives as hsp90 inhibitors |